Skip to main content

Table 3 Non-hemodialysis patients’ demographic profiles, backgrounds, levofloxacin concentrations, and protein binding ratios

From: No effect of protein binding ratio of levofloxacin in hemodialysis patients

Patient no. Age (years) Sex BW (kg) Scr (mg/dL) BST (h) SP (g/dL) SA (g/dL) LVFX (mg/L) PBR (%)
1 59 Female 63.8 0.9 Just before administration 6.6 3.7 4.8 38.8
2 95 Female 35.0 0.7 Just before administration 6.2 2.9 7.7 31.6
3 88 Female 33.3 0.4 Just before administration 6.3 3.4 3.1 37.5
4 87 Female 32.8 0.4 Just before administration 6.8 3.0 1.2 27.7
5 72 Male 43.9 1.0 12 h 5.9 2.6 5.7 24.8
6 86 Female 57.2 1.0 12 h 5.9 3.3 7.4 27.0
7 79 Female 45.7 0.5 Just before administration 6.7 2.8 1.6 31.2
Average 80.9 44.5 0.7 6.3 3.1 4.5 31.2
SD 12.1 12.2 0.3 0.4 0.4 2.6 5.3
  1. SD standard deviation, BW body weight, Scr serum creatinine, BST blood sampling time after administration of levofloxacin, SP serum protein, SA serum albumin, LVFX serum levofloxacin concentration, PBR protein binding ratio